OraSure secures FDA clearance for product seen as key to future growth

OraSure Technologies said the FDA cleared its Colli-Pee™•Dx urine collection kit (from subsidiary DNA Genotek) for at-home first-void urine collection for Roche cobas 5800/6800/8800 molecular testing. The kit supports tests for Chlamydia, Gonorrhea, Trichomonas vaginalis, and Mycoplasma genitalium, enabling mail-in workflows and decentralized STI screening.

Apple sued OpenAI and OpenAI hardware chief Tang Tan in California, alleging a coordinated effort to obtain Apple trade secrets about unreleased products. Apple claims OpenAI employees were encouraged to share confidential materials and that former iPhone engineer Chang Liu accessed dozens of Apple files. OpenAI denies wrongdoing. Apple seeks destruction of materials and product redesigns.

FIRST, via the Sebi-registered India SME Forum, filed a new antitrust complaint with India’s CCI against Walmart-owned Flipkart, alleging deep discounting and anti-competitive conduct that harms over 1.4 million sellers. The filing asks for a Director General investigation, citing alleged misuse of a dominant position. It coincides with Flipkart expanding its zero-commission policy for all fashion products.

Merck & Co. said the FDA approved KEYTRUDA and KEYTRUDA QLEX, each combined with Padcev, for adult muscle-invasive bladder cancer. The regimens are authorized as neoadjuvant therapy before cystectomy and continued as adjuvant therapy after surgery, regardless of cisplatin eligibility. The decision follows Phase 3 KEYNOTE-B15 (EV-304) with 808 patients and expands prior KEYNOTE-905 (EV-303) approval. MRK closed at $123.54.

Jefferies Financial Group reported weaker quarterly asset-management fees and returns, partly tied to its Point Bonita Capital unit, according to Jefferies. Reports say the SEC is investigating whether Jefferies misled investors about exposure to First Brands Group, now bankrupt. Jefferies disclosed a $30 million loss. Jefferies shares fell about 9% to $52.64 on June 25, 2026.

Two environmental groups sued Wisconsin’s DNR, alleging it skipped a full environmental impact statement for Vantage’s Port Washington data center. The groups cite communications showing Vantage sought to avoid the EIS. The project is described as a $15 billion, 672-acre build with 1.3 GW power in phase one. Separate disputes involve a Wisconsin Public Service Commission energy tariff affecting Oracle’s collateral appeal.